November 15, 2013 16:09 ET

Prostate Cancer Expert Visits the TODAY Show on NBC

David B. Samadi, MD, Robotic Prostate Surgeon, Helps Matt Lauer and Al Roker Kick Off "Movember" With On-Air Prostate Cancer Screening

NEW YORK, NY--(Marketwired - Nov 15, 2013) - New York prostate cancer expert, David B. Samadi, MD, was recently featured on the TODAY show to educate viewers on the importance of prostate cancer screening. TODAY hosts Matt Lauer and Al Roker invited Dr. Samadi to help them spread the word about prostate health as part of the nationwide celebration of "Movember" to raise prostate cancer awareness.

Dr. Samadi, a leading robotic prostate surgeon and Chairman of Urology, Chief of Robotic Surgery at Lenox Hill Hospital, conducted live, off-camera digital rectal exams (DREs) for Lauer and Roker to demonstrate the quick, painless test. The 34-second DRE, in conjunction with routine prostate-specific antigen (PSA) testing, is used to monitor prostate health and gather valuable, tactile information and detect nodules or irregularities on the prostate that may require further exploration or monitoring.

"There are no complications associated with prostate cancer screening," stressed Dr. Samadi, who encouraged men to "Get your PSA baseline at the age of 40 and work with your doctor to design a personalized prostate cancer monitoring plan."

PSA testing measures a man's prostate antigen levels. Over time, prostate cancer experts can detect changes in PSA level trends, referred to as PSA velocity. The DRE is often used in partnership with the PSA for a more complete look at the prostate. When an elevated PSA or abnormal features of the prostate are detected, Dr. Samadi typically starts patients on a course of antibiotics, encouraging them to return for follow-ups at six months and one year.

Lauer and Roker represent key prostate cancer risk factor groups. Lauer has a family history of the disease and Roker, as an African American male, is part of a group that is 60 percent more likely to develop prostate cancer, often in a more aggressive form.

"By layering PSA results, DRE findings, and individual risk factors we can better assess a man's prostate cancer status and determine if a prostate biopsy is necessary," said Dr. Samadi. "Routine prostate cancer screening is quick and easy."

Widely regarded for his SMART (Samadi Modified Advanced Robotic Technique) procedure, Dr. Samadi has performed more than 5,200 successful prostate removal surgeries. Cancer-free quality of life is his primary goal; 97 percent of his patients are cancer free. Dr. Samadi's surgery also yields superior results in urinary control and the ability to engage in sex after prostate cancer surgery.

Contact Information

  • David B. Samadi, M.D.
    Chairman of Urology,
    Chief of Robotic Surgery at Lenox Hill Hospital

    Tel: 1-212-365-5000
    Fax: 1-646-692-6744

    485 Madison Avenue
    21st floor
    New York, NY 10022